Healthcare
Tan Tock Seng Hospital and Lucence are developing a next generation decision support tool for liver cancer patients, which aims to reduce the risks associated with liver cancer surgery.
Cerecin continues to strengthen its experienced team in Asia Pacific as it accelerates clinical development plans
Seven proton therapy rooms already sold by IBA this year
Centauri Therapeutics, an immunotherapy company active in oncology and infectious diseases, announces that it will attend the following scientific and investor conferences
Cancer cells appear to adapt to treatment with checkpoint blocker drugs by altering a metabolic process, leading to shorter survival for patients
US FDA 510(k) clearance paves the way for an innovative orthopedic product that offers the potential to improve bone apposition and, as a consequence, patient outcomes 1-3
OMO-1 has potential to treat cancer as a monotherapy and in combination with EGFR TKIs for patients becoming resistant to or progressing on treatment
GE Healthcare is partnering with multiple companies and academic institutions to develop a portfolio of targeted Positron Emission Tomography (PET) tracers to better predict and monitor patient response to immunotherapies.
IBA announces the launch of the development of the world’s first cyclotron-based carbon therapy system in Caen, France through its subsidiary Normandy Hadrontherapy, in collaboration with the Normandy Region and several other private and public players, including SAPHYN.
OECD estimates non adherence to pill regimes cause 200,000 premature deaths a year in EU and costs EUR 125 billion in the US $105 billion in US
PRESS RELEASES